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Introduction 
 
Diarrhoea, defined as >3 loose or liquid stools per day with a volume of greater than 
200g/day1, affects 9.7-41% of Intensive Care Unit (ICU) patients 11-14. Here, it impacts 
negatively on patient dignity, mobility and self-care; increases nursing workload; and can 
cause fluid and electrolyte imbalance, impaired nutritional state and dermal injury. Such 
factors may contribute to the increased patient length of stay  cost of care and mortality 
with which it is associated3,4,5,6,7, 10.  
 
The pathogenesis of diarrhoea in the critically ill is poorly understood8, but factors including 
infection (e.g. C. difficile, norovirus), pancreatic exocrine failure, and the administration of 
feed and or medications (e.g. laxatives, antibiotics)2. as well as changes in the gut 
microbiome, and the structure, function and perfusion of the gut mucosal surface9.  
 
 
In 2016, we reported that 12.9% of 9,331 consecutive patients admitted to the large, mixed 
general ICU at a Central London teaching hospital (University College London Hospitals, 
UCLH) suffered diarrhoea. We also reported that non-infective causes appear to 
predominate, with one fifth of patients receiving laxatives before diarrhoea onset. Finally, 
we found  diarrhoea to be independently associated with ICU  length of stay and mortalit.y10 
 
We sought to determine whether these observations were more generally applicable, by 
studying the ICU patients of a smaller North London district general hospital.  
 
  
Methods 
We performed a service evaluation, registered as an audit with the Whitingto Hpspital NHS 
Trust. All data analysed were fully anonymised. As such, no ethical approval was required.  
 
The Whittington Hospital is a 360-bed teaching hospital located in North London with 
42,000 admissions per year. Computerised records were analysed to identify patients > 18 
years old who were admitted to its 15-bed mixed medical/ surgical ICU/high dependency 
unit (HDU) for level 2 or 3 care in the 60 months between 1/2/2013 to 1/2/2018. The 
Whittington ITU has clearly defined protocols for sending stool samples for microbiological 
or virological analysis, based on the Bristol Stool Chart scoring system.  Consistent with our 
previously published methodology10, patients who had a stool sample sent during their 
admission were judged to have suffered from an episode of diarrhoea.  
 
Stool samples were analysed by microscopy and culture (from February 2013 – June 2017), 
and using bacterial PCR from July 2017 onwards. Based on patient presentation and 
symptoms, samples were also analysed for Clostridium difficile toxin A and B using an 
immunoassay enzyme, C. difficile glutamate dehydrogenase antigen, and Norovirus 1 and 2. 
The presence of C. difficile antigen indicates the presence of a potentially toxin-producing 
organism which is likely associated with disease; therefore the presence of toxin positive 
and toxin negative/ antigen positive samples were classified as positive infectious samples.  
 
Demographic data, including age, sex, admission category (medical or surgical), and Acute 
Physiology and Chronic Health Evaluation (APACHE) II score, were collected. Laxatives 
(including lactulose, senna, macrogol, sodium docusate and ispaghula husk), enemas 
(phosphate) and suppositories (glycerol) received during admission were also documented. 
Measures of outcome including length of stay (LOS) and mortality were recorded. 
 
Patient data were extracted from the ICU database and stool data from the hospital 
laboratory software (ICE Anglia).  A 
 
Statistical Analysis 
Data were compared between patients suffering from diarrhoea, and those not suffering 
diarrhoea. We sought to describe the prevalence of diarrhoea; the proportion of cases in 
which an infective agent was identified; any association with laxative or enema use; and the 
relationship of diarrhoea with ICU length of stay and mortality. xxxx 
Data were analysed using Microsoft Excel 2010. 
 
 
  
Results 
 
Diarrhoea Prevalence: 
Between 1/2/2013 and 1/2/2018, a total of 3,737 patients were admitted to the 
Whittington Hospital ICU (mean +/- xx age 61 +/- 18.9), 1,912 (51.1%) male, 1,328 (35.5%) 
from surgical admissions, median APACHE II score 14 (interquartile range 9-19). Diarrhoea 
was found in 199 patients (prevalence of 5.3%). 
 
Infective aetiology: 
Of the 199 admissions associated with diarrhoea, stool sample analysis suggested an 
infective aetiology in 13 (7%) (see Figure 1): 1/175 (0.006%) of samples sent for bacterial 
microscopy and culture/ PCR, 12/175 (6.9%) of stool sample sent for C. difficile and 0/2 (0%) 
of sample sent for virological analysis. The single positive stool microscopy and culture was 
for Campylobacter. 
 
Out of 12 positive C. difficile samples, 10/12 (83.3%) were antigen positive only, and 2/12 
(16.7%) were toxin positive. C. difficile was the most common infective agent, occurring in 
12 admissions and 11 individual patients (mean age +/- SD 65.6 +/- 14.2, 67% male, 67% 
medical admissions). Three patients were post-operative, with the most common medical 
reason for admission being sepsis (5/9). xxx 
 
No patient tested positive for more than 1 pathogen at any time. 
 
Figure 1: Diarrhoea in the Whittington ITU 
 
 
 
 
Laxatives, suppositories and enemas: 
Of 3,727 ICU patient admissions, 1,005 (26.9%) received laxatives during their stay. Of 199 
diarrhoea cases, 34/199 (17.1%) received laxatives < 24h prior to onset of diarrhoea, while 
3/12 (25%) of C. Diff cases received laxatives within 24h of a positive sample.  
 
Of 3,727 ICU admissions, ^^ received enemas/ suppositories during their stay. Of 199 
diarrhoea cases, 2/199 (1%) received enemas/ suppositories < 24h prior to its onset. 
 
 
 
 
Figure 2: Laxatives administration 
 
 
 
Clinical outcomes: 
Median ICU LOS was 2.5 days (interquartile range 1.1 - 5.5 days) and mortality 11% 
(412/3,737). When compared to those without diarrhoea, patients admitted with diarrhoea 
experienced greater median ICU LOS (median (IQR) 2.3 (1.0-5.0) days vs 10 days (5.0-22.0)) 
and greater ITU mortality (9.5% (356/3,727) vs 18.1% (36/199)). 
 
Median ITU LOS for C. difficile patients was 11.5 days (IQR 2.0-14.3). Five out of 12 (42%) of 
patients with either C. diff toxin or antigen positive samples died during their admission. 
Neither C. diff toxin positive patient (0/2) died during their ITU admission. 
 
Figure 3: Median length of stay 
 
 
 
Figure 4: Mortality 
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Discussion 
 
We found diarrhoea to be common, affecting nearly 1 in 20 admissions to a small district 
general ICU/HDU. It was associated with greater ICU LOS (data, p-value) and also mortality 
(data, p-value). Infective aetiology was uncommon (less than 7% of cases) and use of 
laxatives prior to diarrhoea onset was common (17.1%). 
 
The prevalence of diarrhoea in our unit was lower than the 12.9% that which we had 
previously reported in a large central London ICU (University College London Hospital, 
UCLH)10, and others report a prevalence of 9.7-41%11-14. This may reflect differences in case-
mix: for instance, the proportion of surgical and long-term gastroenterology patients was 
greater at UCLH [data], where the use of tube-feeding was also more common [data]. 
Median APACHE II scores also differed in the two studies(14 at the Whittington vs 16 at 
UCLH- p values for comparison?). Our diagnosis of diarrhoea was dependent on a stool 
sample being sent to the laboratory: whilst this was the same criterion which we had used 
before [ref 10}, the prevalence of milder cases may have been underestimated when 
compared to the studies of others.  
 
In 93% of cases, no enteric infection could be identified in cases (none viral, C. difficile in 6% 
and other bacterial infection in 0.5%).   These data are similar to those at UCLH (prevalence 
of pathological stool samples 7% vs 9.2%; and proportion with non-C Difficile bacterial 
infection 0.5% at both site). However, the proportion of cases with C. difficile infection was 
lower (6% vs 9.3%, p xx) as were the proportion with  viral infection (0% vs 5.2%). These 
differences might partly reflect the smaller sample size of the Whittington study, and 
improved antibiotic stewardship as awareness of the deleterious effects of C. difficile 
become more apparent. Other reports in the literature?] 
 
Overall, 26.9% of admissions received laxatives- a greater proportion than we reported at 
UCLH (17.5%). This difference might be accounted for, in part, by laxatives being a part of an 
electronic software “prescribing bundle” on the unit. [data reported from other units in the 
literature?}  
Some 17.1% of patients received laxatives prior to diarrhoea onset, compared to xx% of 
non-diarrhoea cases (p xx).  [comment- possible causative role? Compare to what we 
reported before?  
Whilst fewer total patients received laxatives prior to diarrhoea onset when compared to 
the UCLH data (17.1% vs 20.2%), more of our C. diff patients (25% vs 13.4%) received 
laxatives within 24h of a positive sample, and fewer received enemas or suppositories (1% 
vs 11.4%) less than 24h prior to diarrhoea onset. Taken together, these data suggest that 
laxative use may be a contributory factor in its aetiology. [other literature? Is such 
prescription part of guidelines?] 
 
Patient length of stay was greater in those affected by  diarrhoea than in those unaffected: 
[our data xx vs yy; p value]. This finding matches that which we made at UCLH (xx vs yy 
respectively, p nn).  [case mix adjustments?  Report nature/ analysis,  and comments as per 
the last paper. Discuss possible causality, with caveats that ‘sicker and longer stay may get 
more chance to have diarrhoea etc.. as per last paper].] We had previously shown that this 
association persists after adjustment for confounding factors- including time from ITU 
admission to developing diarrhoea10, This suggests that a possible causal role for the 
presence of diarrhoea itself in  increasing LOS. Such a role is plausible, as  diarrhoea may 
impair nutrient intake, contribute to dermal injury and to fluid and electrolyte imbalance, 
and increase dependency on higher levels of nursing care.   
C diff LoS data and discussion 
 
 
 Similarly, crude mortality was greater in patients affected by diarrhoea than in those 
without (xx vs yy%, p nn). These data match those identified at UCLH (xx vs yy, p nn). 
[unadjusted and adjusted data; analysis and discussion as per last paper.]. 
C dfiff data and discussion.  
 
 
There were several limitations to this study. As previously stated, the prevalence of 
diarrhoea may have been higher than reported as the diagnosis of diarrhoea depended on a 
stool sample being sent to the laboratory.  However, robust ICU protocols exist to ensure 
that stool samples are sent promptly if an infective cause is suspected. Analysis of electronic 
records did not allow us to adjust for potential iatrogenic confounders, such as antibiotic 
administration, enteral feeding or electrolyte replacement, which have been shown to be 
independent risk factors for diarrhoea15. Moreover, we could not determine any 
relationships of diarrhoea with patient-specific variables, such as the level of organ support, 
co-morbidities or reason for admission. Despite studying data covering a full five year 
period, the number of diarrhoea cases was relatively small. A large-scale prospective study 
would help clarify the imlact of such factors in diarrhoea pathogenesis.  Doing so might 
identify factors amenable to intervention, thus mitigating the financial, morbidity and 
mortality burdens associated with ICU diarrhoea. 
 
In the meantime, robust and regular review of patient’s gastrointestinal status, with prompt 
recognition, investigation and treatment of diarrhoea in light of its association with 
worsening patient outcomes, should be performed. At the Whittington, a trial of removing 
laxatives from the prescribing bundle, and protocolised care to ensure appropriate 
identification of the cause of diarrhoea, management of reversible aetiology, and 
appropriate laxative prescribing, have been suggested as possible ways to reduce the 
burden of this condition. The low diagnostic yield of laboratory investigations for diarrhoea 
suggest that rationalising of investigations could help reduce the financial cost to the 
department; indeed, Manthey et al (2018) suggest that testing for enteric pathogens other 
than C. difficile in ITU should be avoided, and is only reasonable when diarrhoea 
commenced less than 48h after hospital admission16. 
 
In summary, diarrhoea has a prevalence of 5.3% in the Whittington ICU, less than that seen 
in previous studies. The infective burden is low, suggesting another aetiological cause for 
diarrhoea in the critically unwell. Over 17% of our patients with diarrhoea received laxatives 
in the 24h prior to its onset, indicating a need to rationalise prescribing. There is an 
association with increased length of stay and patient mortality in patients with diarrhoea, 
which is increased further in patients with C. difficile. 
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